Dermalive Class Action

Dermalive is a cosmetic filler injected into the skin to smooth out wrinkles and other cosmetic defects. It is alleged that the French manufacturer, Dermatech, and the Canadian distributors, Intradermal Distribution and Vivier Pharma, failed to warn patients and their physicians of the true risks associated with the use of Dermalive.

Nearly eleven thousand units of Dermalive were sold in Canada from 2003 until 2007 when sales in Canada were suspended. Patients world-wide have experienced various degrees of granulomatous reaction, a condition which can leave painful and disfiguring lumps, scarring and permanent disability such as the inability to smile. In many cases of granulomas, there is no cure.

Update: Dermalive Class Action Settlement Finalized

The Settlement: On October 10, 2014, Mr. Justice Sewell of the Supreme Court of British Columbia approved the settlement of a class action for people who developed granulomas after being injected with Dermalive.  Dermalive is a cosmetic filler injected into the skin to smooth out wrinkles and other cosmetic defects. The settlement provides compensation to individuals who establish that they were injected with Dermalive in Canada and developed granulomas in the area injected with Dermalive. Money is also available to reimburse the cost of corrective medical treatment (e.g., steroid injections, laser treatments, surgery, etc.).  The settlement applies to residents of British Columbia who did not opt out of the class action on or before February 15, 2014 and non-BC residents who validly opted into the class action on or before February 15, 2014. Click here to see the Notice of Settlement Approval, Settlement Agreement, Distribution Protocol, Claim Form and Physician Form.

Deadline: To be eligible for compensation, the Class Member or someone with authority to act on his or her behalf must submit a completed claim form and completed physician form together with copies of medical records, receipts, or other documentation which shows that the Class Member was injected with Dermalive in Canada, that the Class Member developed granulomas, what treatment the Class Member received for the granulomas, and what treatments were paid for by the Class Member. The completed claim form, physician form, and all supporting documentation (i.e., medical records, receipts, etc.) must be delivered or postmarked to the Dermalive Class Action Claims Registry, c/o Bruneau Group, 390 Rideau St. – Box 20187, Ottawa, ON K1N 9P4, by no later than by May 20, 2015.

Relevant Documents:

  1. Settlement Agreement
  2. Notice of Settlement Approval
  3. Distribution Protocol
  4. Physician Form
  5. Claim Form

Getting Information: For more information about making a claim, contact the Administrator:

Bruneau Group
Address: 390 Rideau St. – Box 20187, Ottawa, ON K1N 9P4
Toll free 1-866-262-0006
Telephone: 613-562-3646
Fax: 1-866-262-0816 or 613-562-0321
Email: info@dermaliveclaim.ca

Class Action Contact
Class Actions
Lemon Creek Fuel Spill Class Action

Certified class action concerning the spill of 35,000 litres of jet fuel into the Slocan Valley region of British Columbia.

Lap-Band Class Action

Proposed class action concerning the failure rate of the adjustable gastric band implant known as Lap-Band.

HIV/AIDS Privacy Class Action

Proposed class action against the University of British Columbia and others for unlawfully disclosing the HIV+ status of nearly eight-hundred residents of British Columbia.

Air Transat Class Action

Proposed class action against Air Transat with respect to the misrepresentation of direct flight segments and the consequent overcharge to customers.

Physiomesh Class Action

Proposed class action concerning the Ethicon Physiomesh Composite Mesh Device, which was recalled by Health Canada due to its dangerous design defects.

Share This